Save up -80% on Pergolide

Note: this is a drug discount program, not an insurance plan.

RX BIN: 015558
RX PCN: HT
Group ID: DDN6600
Card Holder ID: DDN6600

Pharmacists and Patients support.

2018 Price of Pergolide

Pergolide mesylate 100% powder

$1009.8

g

* price without discount in nearest pharmacy. Price may vary.

Claim your free Pergolide discount card

We offer free Pergolide coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your discount card in most local pharmacies to get a discount on Pergolide every time. What are you waiting for? Claim your prescription drug card now!

Get your Prescription
It’s safe and free
Buy drugs in pharmacy
Save money each time

Pergolide volume of distribution

About RX24Drugs

Discount Cards 16,000+

Clients Benefit 29%

Total savings $4,735,080

What is Pergolide

Pergolide is a long-acting dopamine agonist approved in 1982 for the treatment of Parkinsons Disease. It is an ergot derivative that acts on the dopamine D2 and D3, alpha2- and alpha1-adrenergic, and 5-hydroxytryptamine (5-HT) receptors. It was indicated as adjunct therapy with levodopa/carbidopa in the symptomatic treatment of parkinsonian syndrome. It was later found that pergolide increased the risk of cardiac valvulopathy. The drug was withdrawn from the US market in March 2007 and from the Canadian market in August 2007.

Pergolide mechanism of action

The dopamine D sub2 /sub receptor is a 7-transmembrane G-protein coupled receptor associated with G subi /sub proteins. In lactotrophs, stimulation of dopamine D sub2 /sub receptor causes inhibition of adenylyl cyclase, which decreases intracellular cAMP concentrations and blocks IP3-dependent release of Ca sup2+ /sup from intracellular stores. Decreases in intracellular calcium levels may also be brought about via inhibition of calcium influx through voltage-gated calcium channels, rather than via inhibition of adenylyl cyclase. Additionally, receptor activation blocks phosphorylation of p42/p44 MAPK and decreases MAPK/ERK kinase phosphorylation. Inhibition of MAPK appears to be mediated by c-Raf and B-Raf-dependent inhibition of MAPK/ERK kinase. Dopamine-stimulated growth hormone release from the pituitary gland is mediated by a decrease in intracellular calcium influx through voltage-gated calcium channels rather than via adenylyl cyclase inhibition. Stimulation of dopamine D sub2 /sub receptors in the nigrostriatal pathway leads to improvements in coordinated muscle activity in those with movement disorders.

Dosage forms of Pergolide

FormRouteStrength
Tabletoral0.05 mg
Tabletoral0.25 mg
Tabletoral1 mg
Prescription Generics

false

International Brands

Permax Tab 0.05mg

Synonyms

Pergolida Pergolide Mesylate

Manufacturers

Eli Lilly Canada Inc

CAS number

66104-22-1

UNII

24MJ822NZ9

State

solid

Affected organisms

Humans and other mammals

Indication of Pergolide

Indicated as adjunctive treatment to levodopa/carbidopa in the management of the signs and symptoms of Parkinson‘s disease. It was withdrawn from the US and Canadian markets in 2007 due to an increased risk of cardiac valvulopathy.

Toxicity of Pergolide

Oral, rat LD sub50 /sub: 15 mg/kg. Symptoms of overdose include nausea, vomiting, convulsions, decreased blood pressure, and CNS stimulation.

RX24 Drugs Disclaimer: before buying a Pergolide on prescription, consult your healthcare provider. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.

Get lower price on Pergolide now!